SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (29470)11/24/1999 3:14:00 PM
From: Henry Niman  Respond to of 32384
 
I hope that the Targretin approval goes as smoothly and quickly as Panretin. I don't think that the FDA is interested in discussing the final details until they have an approval recommendation from their advisory board.



To: Mudcat who wrote (29470)11/24/1999 3:24:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
The complaints are coming early this year. Last year you were complaining after the approvable letter:
Message 6617841
Message 6667446
Message 6668546
Message 6670414
Message 6681604


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News